Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The price of Kintara Therapeutics Inc (NASDAQ: KTRA) closed at $0.15 in the last session, down -3.75% from day before closing price of $0.16. In other words, the price has decreased by -$3.75 from its previous closing price. On the day, 2.81 million shares were traded. KTRA stock price reached its highest trading level at $0.1624 during the session, while it also had its lowest trading level at $0.1499.
Ratios:
We take a closer look at KTRA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.63 and its Current Ratio is at 0.63.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KTRA now has a Market Capitalization of 5906434 and an Enterprise Value of 15386434.
Stock Price History:
The Beta on a monthly basis for KTRA is 0.47, which has changed by -0.9509375 over the last 52 weeks, in comparison to a change of 0.22379243 over the same period for the S&P500. Over the past 52 weeks, KTRA has reached a high of $5.98, while it has fallen to a 52-week low of $0.08. The 50-Day Moving Average of the stock is 34.38%, while the 200-Day Moving Average is calculated to be -90.48%.
Shares Statistics:
According to the various share statistics, KTRA traded on average about 14.68M shares per day over the past 3-months and 10532100 shares per day over the past 10 days. A total of 55.30M shares are outstanding, with a floating share count of 55.20M. Insiders hold about 0.19% of the company’s shares, while institutions hold 0.40% stake in the company. Shares short for KTRA as of 1713139200 were 700043 with a Short Ratio of 0.05, compared to 1710460800 on 2196731. Therefore, it implies a Short% of Shares Outstanding of 700043 and a Short% of Float of 1.79.
Earnings Estimates
On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0 and a low estimate of $0, while EPS last year was -$3.5. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between -$0.46 and -$0.46 for the fiscal current year, implying an average EPS of -$0.46. EPS for the following year is -$0.38, with 1.0 analysts recommending between -$0.38 and -$0.38.
